Early assessment, diagnosis and treatment of Parkinsonism and Related Syndromes study (ExPRESS): a protocol for an observational study on incident parkinsonism
Riona Giulia Fumi, Isabella Caraiscos, Edwin Jabbari, Timothy Rittman, James B Rowe, Yoav Ben-Shlomo, Michele T Hu, Huw R Morris · 2026
Read Early assessment, diagnosis and treatment of Parkinsonism and Related Syndromes study (ExPRESS): a protocol for an observational study on incident parkinsonism by Riona Giulia Fumi, Isabella Caraiscos, Edwin Jabbari, Timothy Rittman, James B Rowe, Yoav Ben-Shlomo, Michele T Hu, Huw R Morris (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13479499.txt.
Description
Fumi and colleagues present a 2026 protocol for ExPRESS, a United Kingdom study of people newly showing parkinsonism, the movement problems seen in Parkinson's disease and rarer related syndromes. Two related syndromes, progressive supranuclear palsy and multiple system atrophy, take over three years to diagnose, far longer than Parkinson's itself. The study will follow 500 people within a year of their first specialist visit.
Participants will fill in symptom questionnaires and receive a structured nerve and movement exam that records key clinical features. The team will track how diagnoses evolve over time and test which early features best predict the rare syndromes. A second aim is a trial-ready patient group, so drug trials can recruit fast. Earlier diagnosis matters because trials need patients while treatment can still help.
Catalog record
| CREATOR | Riona Giulia Fumi, Isabella Caraiscos, Edwin Jabbari, Timothy Rittman, James B Rowe, Yoav Ben-Shlomo, Michele T Hu, Huw R Morris |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |